Works matching IS 22351795 AND DT 2023 AND VI 12
Results: 64
The 13th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2023).
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, p. 1, doi. 10.1159/000531751
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 1, doi. 10.1159/000535679
- Publication type:
- Article
Contents.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 605, doi. 10.1159/000535164
- Publication type:
- Article
Acknowledgment to Reviewers.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 603, doi. 10.1159/000534661
- Publication type:
- Article
Current Therapeutic Strategies for Hepatocellular Carcinoma in Japan.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 539, doi. 10.1159/000529143
- By:
- Publication type:
- Article
Real-Time Fluorescence Imaging to Identify Cholangiocarcinoma in the Extrahepatic Biliary Tree Using an Enzyme-Activatable Probe.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 590, doi. 10.1159/000530645
- By:
- Publication type:
- Article
Transcatheter Arterial Chemoembolization for Treatment-Naive Hepatocellular Carcinoma Has Different Treatment Effects Depending on Central or Peripheral Tumor Location.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 576, doi. 10.1159/000530441
- By:
- Publication type:
- Article
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078
- By:
- Publication type:
- Article
Computed Tomography-Defined Sarcopenia in Outcomes of Patients with Unresectable Hepatocellular Carcinoma Undergoing Radioembolization: Assessment with Total Abdominal, Psoas, and Paraspinal Muscles.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 550, doi. 10.1159/000529676
- By:
- Publication type:
- Article
Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 510, doi. 10.1159/000533166
- By:
- Publication type:
- Article
Adverse Events of Immune Checkpoint Inhibitor-Based Therapies for Unresectable Hepatocellular Carcinoma in Prospective Clinical Trials: A Systematic Review and Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 521, doi. 10.1159/000528698
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 1, doi. 10.1159/000534621
- Publication type:
- Article
All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 395, doi. 10.1159/000533493
- By:
- Publication type:
- Article
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition).
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 405, doi. 10.1159/000530495
- By:
- Publication type:
- Article
Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 494, doi. 10.1159/000530300
- By:
- Publication type:
- Article
Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 479, doi. 10.1159/000529996
- By:
- Publication type:
- Article
Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 445, doi. 10.1159/000529824
- By:
- Publication type:
- Article
Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 467, doi. 10.1159/000529635
- By:
- Publication type:
- Article
Association between Smoking Cessation and the Risk of Cholangiocarcinoma and Ampulla of Vater Cancer: A Nationwide Cohort Study.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 457, doi. 10.1159/000529609
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 288, doi. 10.1159/000534256
- Publication type:
- Article
Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 289, doi. 10.1159/000532023
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 309, doi. 10.1159/000529636
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2023
- Publication type:
- Correction Notice
Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 339, doi. 10.1159/000529608
- By:
- Publication type:
- Article
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 321, doi. 10.1159/000529574
- By:
- Publication type:
- Article
Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 372, doi. 10.1159/000529173
- By:
- Publication type:
- Article
Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 297, doi. 10.1159/000528537
- By:
- Publication type:
- Article
Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Hepatocellular Carcinoma ≤5 cm: Biological Characteristics and Patient Outcomes.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 356, doi. 10.1159/000527498
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 1, doi. 10.1159/000533455
- Publication type:
- Article
Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 189, doi. 10.1159/000531225
- By:
- Publication type:
- Article
Genomic and Immune Features in an Intrahepatic Cholangiocarcinoma Patient with Microsatellite Instability-High Suffered Rapid Acquired Resistance to PD-1 Inhibitor.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 198, doi. 10.1159/000530134
- By:
- Publication type:
- Article
Efficacy of Local Treatment in Lymph Node Metastasis from Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 218, doi. 10.1159/000529201
- By:
- Publication type:
- Article
Trends and Disparities in Stage-Specific Incidence of Hepatocellular Carcinoma among US Adults, 2004–2019.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 277, doi. 10.1159/000528374
- By:
- Publication type:
- Article
Outcomes of Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma Converted by Transcatheter Arterial Chemoembolization Combined with Lenvatinib plus Anti-PD-1 Antibodies: A Multicenter Retrospective Study.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 229, doi. 10.1159/000528356
- By:
- Publication type:
- Article
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 238, doi. 10.1159/000528272
- By:
- Publication type:
- Article
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 251, doi. 10.1159/000528145
- By:
- Publication type:
- Article
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 262, doi. 10.1159/000528034
- By:
- Publication type:
- Article
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
- By:
- Publication type:
- Article
APPLE News.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000530731
- Publication type:
- Article
Surveillance, Diagnosis, and Treatment Outcome of Hepatocellular Carcinoma in Japan: 2023 Update.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000530079
- By:
- Publication type:
- Article
Long-Term Regression after Discontinuation of Regorafenib Administered for Sorafenib-Refractory Hepatocellular Carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Elderly Patients with Hepatocellular Carcinoma Benefit from Liver Transplantation as Much as Younger Ones.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000528830
- By:
- Publication type:
- Article
Imaging Diagnosis of Various Hepatocellular Carcinoma Subtypes and Its Hypervascular Mimics: Differential Diagnosis Based on Conventional Interpretation and Artificial Intelligence.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000528538
- By:
- Publication type:
- Article
Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000527836
- By:
- Publication type:
- Article
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000527759
- By:
- Publication type:
- Article
Regorafenib versus Cabozantinib as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: An Anchored Matching-Adjusted Indirect Comparison of Efficacy and Safety.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000527403
- By:
- Publication type:
- Article
Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
PD-1/CTLA-4 Blockade Leads to Expansion of CD8<sup>+</sup>PD-1<sup>int</sup> TILs and Results in Tumor Remission in Experimental Liver Cancer.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000526899
- By:
- Publication type:
- Article